Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors

Abstract excerpt

BACKGROUND: Stage D1 disease is found in at least every sixth patient undergoing bilateral pelvic lymphadenectomy and radical retropubic prostatectomy (RRP) for clinically localized prostate cancer (PC). Previous recommendations for monotherapy using surgery, radiation, or systemic therapy alone for Stage D1 disease have usually been associated with a poor outcome in regard to progression and survival. Unlike...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced Radiotherapy Techniques
• Share to Prostate Cancer Diagnosis and Treatment
• Share to Prostate Cancer Treatment and Research